Literature DB >> 18924611

The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo.

Milica Vukmanovic-Stejic1, Elaine Agius, Nicola Booth, Padraic J Dunne, Katie E Lacy, John R Reed, Toni O Sobande, Steven Kissane, Mike Salmon, Malcolm H Rustin, Arne N Akbar.   

Abstract

Naturally occurring CD4(+)CD25(hi)Foxp3(+) Tregs (nTregs) are highly proliferative in blood. However, the kinetics of their accumulation and proliferation during a localized antigen-specific T cell response is currently unknown. To explore this, we used a human experimental system whereby tuberculin purified protein derivative (PPD) was injected into the skin and the local T cell response analyzed over time. The numbers of both CD4(+)Foxp3(-) (memory) and CD4(+)Foxp3(+) (putative nTreg) T cells increased in parallel, with the 2 populations proliferating at the same relative rate. In contrast to CD4(+)Foxp3(-) T cell populations, skin CD4(+)Foxp3(+) T cells expressed typical Treg markers (i.e., they were CD25(hi), CD127(lo), CD27(+), and CD39(+)) and did not synthesize IL-2 or IFN-gamma after restimulation in vitro, indicating that they were not recently activated effector cells. To determine whether CD4(+)Foxp3(+) T cells in skin could be induced from memory CD4(+) T cells, we expanded skin-derived memory CD4(+) T cells in vitro and anergized them. These cells expressed high levels of CD25 and Foxp3 and suppressed the proliferation of skin-derived responder T cells to PPD challenge. Our data therefore demonstrate that memory and CD4(+) Treg populations are regulated in tandem during a secondary antigenic response. Furthermore, it is possible to isolate effector CD4(+) T cell populations from inflamed tissues and manipulate them to generate Tregs with the potential to suppress inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18924611      PMCID: PMC2556297          DOI: 10.1172/JCI35834

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  65 in total

1.  Type 1 IFN maintains the survival of anergic CD4+ T cells.

Authors:  G Lombardi; P J Dunne; D Scheel-Toellner; T Sanyal; D Pilling; L S Taams; P Life; J M Lord; M Salmon; A N Akbar
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

Review 2.  Regulatory T cells and infection: a dangerous necessity.

Authors:  Yasmine Belkaid
Journal:  Nat Rev Immunol       Date:  2007-11       Impact factor: 53.106

3.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

4.  Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.

Authors:  L S Taams; J Smith; M H Rustin; M Salmon; L W Poulter; A N Akbar
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

5.  Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.

Authors:  D M Patel; P Y Arnold; G A White; J P Nardella; M D Mannie
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

6.  Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

Authors:  S Gregori; M Casorati; S Amuchastegui; S Smiroldo; A M Davalli; L Adorini
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

Review 7.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

8.  Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.

Authors:  Leonie S Taams; Milica Vukmanovic-Stejic; Jay Smith; Padraic J Dunne; Jean M Fletcher; Fiona J Plunkett; Saskia B Ebeling; Giovanna Lombardi; Malcolm H Rustin; Johannes W J Bijlsma; Floris P J G Lafeber; Mike Salmon; Arne N Akbar
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

9.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.

Authors:  Lucy S K Walker; Anna Chodos; Mark Eggena; Hans Dooms; Abul K Abbas
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  62 in total

1.  Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.

Authors:  Damien Bresson; Georgia Fousteri; Yulia Manenkova; Michael Croft; Matthias von Herrath
Journal:  J Autoimmun       Date:  2011-11-06       Impact factor: 7.094

Review 2.  Role of Metabolism in the Immunobiology of Regulatory T Cells.

Authors:  Mario Galgani; Veronica De Rosa; Antonio La Cava; Giuseppe Matarese
Journal:  J Immunol       Date:  2016-10-01       Impact factor: 5.422

3.  Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis.

Authors:  Ute Laggner; Paola Di Meglio; Gayathri K Perera; Christian Hundhausen; Katie E Lacy; Niwa Ali; Catherine H Smith; Adrian C Hayday; Brian J Nickoloff; Frank O Nestle
Journal:  J Immunol       Date:  2011-08-03       Impact factor: 5.422

4.  mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells.

Authors:  Im-Hong Sun; Min-Hee Oh; Liang Zhao; Chirag H Patel; Matthew L Arwood; Wei Xu; Ada J Tam; Richard L Blosser; Jiayu Wen; Jonathan D Powell
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

5.  Development of Type 2, But Not Type 1, Leprosy Reactions is Associated with a Severe Reduction of Circulating and In situ Regulatory T-Cells.

Authors:  Ana Paula Vieira; Maria Ângela Bianconcini Trindade; Carla Pagliari; João Avancini; Neusa Yurico Sakai-Valente; Alberto José da Silva Duarte; Gil Benard
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

Review 6.  Regulatory T cells in nonlymphoid tissues.

Authors:  Dalia Burzyn; Christophe Benoist; Diane Mathis
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

7.  Enhanced generation of suppressor T cells in patients with asthma taking oral contraceptives.

Authors:  A Catalina Vélez-Ortega; James Temprano; Mary Catherine Reneer; Gavin I Ellis; Andrea McCool; Tonya Gardner; Mehdi Khosravi; Francesc Marti
Journal:  J Asthma       Date:  2013-02-05       Impact factor: 2.515

8.  Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging.

Authors:  Elaine Agius; Katie E Lacy; Milica Vukmanovic-Stejic; Ann L Jagger; Anna-Pia Papageorgiou; Sue Hall; John R Reed; S John Curnow; Judilyn Fuentes-Duculan; Christopher D Buckley; Mike Salmon; Leonie S Taams; James Krueger; John Greenwood; Nigel Klein; Malcolm H A Rustin; Arne N Akbar
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

9.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 10.  Therapeutic cancer vaccines in combination with conventional therapy.

Authors:  Mads Hald Andersen; Niels Junker; Eva Ellebaek; Inge Marie Svane; Per Thor Straten
Journal:  J Biomed Biotechnol       Date:  2010-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.